Lexicon Stock Valuation

LXRX
 Stock
  

USD 2.07  0.02  0.98%   

Do you wonder what the value of Lexicon Pharmaceutcl is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Lexicon Pharmaceutcl, is its stock price multiplied by the total number of shares outstanding, calculating Lexicon Pharmaceutcl's enterprise value requires a different approach. It uses Lexicon Pharmaceutcl's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Lexicon Pharmaceutcl Enterprise Value is fairly stable at the moment as compared to the past year. Lexicon Pharmaceutcl reported Enterprise Value of 506.22 Million in 2021. Tangible Asset Value is likely to rise to about 94.8 M in 2022, whereas Free Cash Flow is likely to drop (95.2 M) in 2022.
Lexicon Pharmaceutcl secures a last-minute Real Value of $3.02 per share. The latest price of the firm is $2.07. Based on Macroaxis valuation methodology, the firm appears to be undervalued. Our model forecasts the value of Lexicon Pharmaceutcl from analyzing the firm fundamentals such as Current Valuation of 350.9 M, shares owned by insiders of 1.03 %, and Return On Equity of (93.04) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend acquiring undervalued stocks and dropping overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
  
Lexicon Pharmaceutcl Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Lexicon Pharmaceutcl's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Lexicon Most Recent Valuation Data

Price Book
2.79
EPS Estimate Next Quarter
(0.14) 
Price Sales
K
EBITDA
-95.4 M
Beta
1.36
Fiscal Year End
December
Undervalued
Today 2.07
Please note that Lexicon Pharmaceutcl's price fluctuation is risky at this time. Calculation of the real value of Lexicon Pharmaceutcl is based on 3 months time horizon. Increasing Lexicon Pharmaceutcl's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Lexicon Pharmaceutcl is useful when determining the fair value of the Lexicon stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Lexicon Pharmaceutcl. Since Lexicon Pharmaceutcl is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lexicon Stock. However, Lexicon Pharmaceutcl's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
3.02
Real Value
7.03
Upside
Estimating the potential upside or downside of Lexicon Pharmaceutcl helps investors to forecast how Lexicon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lexicon Pharmaceutcl more accurately as focusing exclusively on Lexicon Pharmaceutcl's fundamentals will not take into account other important factors:
Earnings
Estimates (1)
LowProjected EPSHigh
-0.6-0.6-0.6
Details
Hype
Prediction
LowEstimated ValueHigh
0.102.076.08
Details
Naive
Forecast
LowNext ValueHigh
0.037381.875.88
Details
1 Analysts
Consensus
LowTarget PriceHigh
6.006.006.00
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Lexicon Pharmaceutcl's intrinsic value based on its ongoing forecasts of Lexicon Pharmaceutcl's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Lexicon Pharmaceutcl's closest peers. When choosing an evaluation method for Lexicon Pharmaceutcl, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Lexicon Pharmaceutcl Investments

23.27 Million

Lexicon Valuation Drivers Correlation

Many accounts on the financial statements of Lexicon Pharmaceutcl are highly interrelated and sometimes correlated. Consequently, when conducting Lexicon's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Lexicon
Click cells to compare fundamentals

Lexicon Valuation Trend

Knowing Lexicon Pharmaceutcl's actual value is paramount for traders to make sound investment determinations. Lexicon Pharmaceutcl's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Lexicon Pharmaceutcl's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Lexicon Pharmaceutcl's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Lexicon Market Cap

Lexicon Pharmaceutcl is rated second overall in market capitalization category among related companies. Market capitalization of Biotechnology industry is now estimated at about 271.75 Billion. Lexicon Pharmaceutcl adds roughly 317.15 Million in market capitalization claiming only tiny portion of stocks in Biotechnology industry.
Capitalization  Revenue  Valuation  Total debt  Workforce

Lexicon Pharmaceutcl Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Lexicon Pharmaceutcl's current stock value. Our valuation model uses many indicators to compare Lexicon Pharmaceutcl value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lexicon Pharmaceutcl competition to find correlations between indicators driving Lexicon Pharmaceutcl's intrinsic value. More Info.
Lexicon Pharmaceutcl is currently regarded as number one stock in price to earning category among related companies. It is currently regarded as number one stock in beta category among related companies totaling about  0.07  of Beta per Price to Earning. The ratio of Price to Earning to Beta for Lexicon Pharmaceutcl is roughly  14.40 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Lexicon Pharmaceutcl by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Lexicon Pharmaceutcl's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lexicon Pharmaceutcl's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Lexicon Pharmaceutcl's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Lexicon Pharmaceutcl and how it compares across the competition.

About Lexicon Pharmaceutcl Valuation

The stock valuation mechanism determines the current worth of Lexicon Pharmaceutcl on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Lexicon Pharmaceutcl. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Lexicon Pharmaceutcl based exclusively on its fundamental and basic technical indicators. By analyzing Lexicon Pharmaceutcl's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Lexicon Pharmaceutcl's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lexicon Pharmaceutcl. We calculate exposure to Lexicon Pharmaceutcl's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lexicon Pharmaceutcl's related companies.
Fiscal Year End
December
Industry
Biotechnology
Concentration
Biotechnology
Full Time Employees
87.0
Service Category
Biotechnology
Employer Id Number
76-0474169
Last ReportedProjected for 2022
Gross Profit298 K305.8 K
Profit Margin 36.36  39.23 

Lexicon Pharmaceutcl Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Lexicon Pharmaceutcl does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio3.68
Revenue Growth-85.00%
Enterprise Value To Ebitda-3.68
Enterprise Value To Revenue3,219.31

Lexicon Pharmaceutcl Current Valuation Indicators

Valuation refers to the process of determining the present value of Lexicon Pharmaceutcl and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Lexicon we look at many different elements of the entity such as Lexicon's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Lexicon Pharmaceutcl's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Lexicon Pharmaceutcl's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Lexicon Pharmaceutcl, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Lexicon Pharmaceutcl's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Lexicon Pharmaceutcl's worth.
Additionally, see Correlation Analysis. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for analysis

When running Lexicon Pharmaceutcl price analysis, check to measure Lexicon Pharmaceutcl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceutcl is operating at the current time. Most of Lexicon Pharmaceutcl's value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceutcl's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lexicon Pharmaceutcl's price. Additionally, you may evaluate how the addition of Lexicon Pharmaceutcl to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Is Lexicon Pharmaceutcl's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexicon Pharmaceutcl. If investors know Lexicon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lexicon Pharmaceutcl listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.63) 
Market Capitalization
381.2 M
Quarterly Revenue Growth YOY
0.7
Return On Assets
(0.33) 
Return On Equity
(0.69) 
The market value of Lexicon Pharmaceutcl is measured differently than its book value, which is the value of Lexicon that is recorded on the company's balance sheet. Investors also form their own opinion of Lexicon Pharmaceutcl's value that differs from its market value or its book value, called intrinsic value, which is Lexicon Pharmaceutcl's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexicon Pharmaceutcl's market value can be influenced by many factors that don't directly affect Lexicon Pharmaceutcl's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexicon Pharmaceutcl's value and its price as these two are different measures arrived at by different means. Investors typically determine Lexicon Pharmaceutcl value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexicon Pharmaceutcl's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.